Actos Bladder Cancer Concerns

Actos Bladder Cancer Lawsuit Actos is a recent drug in the thiazolidinedione class, which is used by itself or in combination with other drugs (including insulin) for the treatment of type 2 diabetes. The medicine lowers blood glucose levels and increases the body’s sensitivity to insulin.  The US Food and Drug Administration (FDA) approved Actos … [Read more...]

Drug Manufacturer Watson Sues FDA Over Generic Actos Release

Watson Pharmaceuticals has filed a lawsuit against the FDA for denying shared exclusivity, despite the fact that the drug company followed all the FDA’s requirements. Watson planned to release the generic version of Takeda Pharmaceutical’s controversial Actos drug on August 17th. In 2010, Watson got approval to market the generic pioglitazone … [Read more...]

Study Reveals Obesity Rates in the South are Some of Highest in the Country; South Carolina Places 8th

A new study shows that 12 states have obesity rates higher than 30%, and 26 of the 30 states with high obesity rates are in the South and Midwest. South Carolina ranks number 8 in the study, with an obesity rate of 30.8%. Five years ago, South Carolina ranked 10th in the nation, with between three or four people dying each day from diabetes and … [Read more...]

Actos Increases Bladder Cancer Risk Compared to Different Class of Diabetes Drugs

A new study released earlier this month, and published in the Journal of the National Cancer Institute, found that thiazolidinedione (TZD) drugs like Actos were more likely to cause bladder cancer than a different class of drugs called sulfonylurea drugs. Patients who took TZD drugs were two to three times more likely to develop bladder cancer than … [Read more...]

Product Liability Lawsuits Against Actos Begin

Two Women File Product Liability Lawsuits Against Actos Two women filed a product liability lawsuit against Actos after they developed bladder cancer. The trial began on Monday, March 10th, in Clark County, Nevada. The trial has not become part of the Actos MDL against Takeda Pharmaceuticals. The plaintiffs – Delores Cipriano, 81, of Henderson, … [Read more...]

Takeda Offers Three New Drugs with Same Active Ingredient as Actos

After Winning FDA Approval for Actos’ Active Ingredient Alogliptin, Takeda Will Offer Three New Drugs After much back and forth with the FDA, Takeda Pharmaceuticals – the manufacturers of the controversial and dangerous Type 2 diabetes drug, Actos – have won approval for new formulations of the active ingredient alogliptin. Actos, the … [Read more...]

Jury Told Takeda Hid Risk of Cancer from Actos

Plaintiff Claims Takeda Knew About Bladder Cancer Risk from Actos, Hid Information As the first bellwether trial in the Actos multidistrict lawsuit (MDL) begins, the plaintiff’s attorney claims that Takeda Pharmaceuticals, manufacturers of Type 2 diabetes drug Actos, intentionally withheld information linking their blockbuster drug to bladder … [Read more...]

Jury Can Hear Claims Regarding Destroyed Actos Files

Judge Rules that Jury in Actos MDL Can Hear Evidence Regarding Destroyed Actos Files As the first bellwether trial in the Actos multidistrict litigation (MDL) begins the week of January 30th, Judge Rebecca Doherty ruled that the jury can hear evidence claiming that Takeda Pharmaceuticals destroyed files containing evidence that Actos could cause … [Read more...]

Actos Bellwether Cases Scheduled for MDL 2299

Presiding Judge Rebecca Doherty has issued a detailed schedule for proceedings in the Actos Multidistrict Litigation (MDL) 2299. Bellwether trials, which are typical in MDLs, are early trials designed by both parties to gauge the juries’ reactions to evidence. The trials picked as bellwether cases normally represent egregious cases. Attorneys … [Read more...]

Actos Lawsuit

The Strom Law Firm is now accepting product liability and personal injury cases regarding the use of Actos and its link to bladder cancer.  Call us right now for a free case review to see if we can help you. 803.252.4800 Actos drug maker Takeda Pharmaceutical Co. Ltd. was hit in California yesterday with what is expected to be the first of … [Read more...]

BestLawyers.comAVBetter Business Bureau